With over 35 years of experience in the pharmaceutical industry, Joe Mather is a visionary leader and innovator in molecular pharmacology and drug discovery. He is currently the Head of Research Diagnostics at Pfizer, where he leads the development team behind Lucira by Pfizer, a novel and rapid at-home COVID-19 & Flu nucleic acid test kit that has revolutionized the diagnosis and management of infectious diseases.Joe also has responsibility for the Digital Science group in Pfizer's Early Clinical Development Organization, focusing on validating digital health technologies, qualified novel digital endpoints, and the expansion of decentralized trial capabilities. He is passionate about advancing digital medicine and improving patient outcomes, and he serves as a Scientific Advisor at Cumulus Neuroscience, a leading company in developing digital biomarkers for brain health. Joe's mission is to leverage his expertise and experience to create innovative and impactful solutions for the global health challenges of the 21st century.